|
Hearken to this text  |
Microbot Medical’s LIBERTY system is a single-use endovascular robotic surgical system. | Supply: Microbot Medical
Microbot Medical Inc., the developer of the LIBERTY Endovascular Robotic Surgical System, is constructing on the momentum from the optimistic outcomes of its good laboratory practices, or GLP, pre-clinical examine. The corporate is including a medical analysis affiliate to help its pending investigational machine exemption, or IDE, submission to start its first-in-human medical trial.
The medical analysis affiliate (CRA) will be part of the Braintree Mass.-based firm‘s established medical staff within the U.S. The staff is led by Dr. Juan Diaz-Cartelle, chief medical officer of Microbot Medical.
“Following the profitable completion of our pivotal GLP pre-clinical trial, and as we’re within the last stage of submitting our IDE, having an in-house CRA is a key piece for establishing the precise infrastructure for medical trial execution” stated Diaz-Cartelle in a launch.
Be taught from Agility Robotics, Amazon, Disney, Teradyne and lots of extra.
Microbot Medical goals to enhance endovascular surgical procedures
Microbot Medical’s LIBERTY system goals to enhance using surgical robotics in endovascular procedures. The system eliminates the necessity for big, cumbersome, and costly capital gear, in keeping with the firm. It will possibly additionally scale back radiation publicity and doctor pressure.
In December 2023, Microbot Medical accomplished a pre-clinical examine of its LIBERTY system. The pre-clinical examine is a needed step towards Microbot Medical’s IDE submission to the U.S. Meals and Drug Administration (FDA). Through the examine, three interventional radiologists used LIBERTY to carry out a complete of 96 robotic navigations.
The radiologists used LIBERTY to look at and consider goal vessels with surrounding tissue microscopically after subjecting them to procedures utilizing a spread of commercially obtainable intravascular catheterization units. All of those units had been managed and manipulated with Microbot Medical’s system.
LIBERTY is a single-use endovascular system. No devoted infrastructure is required to make use of the system. This may decrease limitations to acquiring and utilizing the system, making the know-how obtainable to extra healthcare suppliers, claimed Microbot Medical.
Microbot groups up with Corewell Well being
Microbot Medical is collaborating with Corewell Well being for a multi-phase venture to allow telerobotics between distant facilities. The settlement additionally consists of the mutual analysis of the LIBERTY system for distant procedures.
Corewell Well being is a not-for-profit well being system with greater than 60,000 staff, together with over 11,500 physicians and superior follow suppliers, and greater than 15,000 nurses. It stated it offers care and companies in 21 hospitals, over 300 outpatient places, and several other post-acute amenities.
Microbot Medical stated it gives micro-robotic applied sciences to enhance medical outcomes for sufferers and improve accessibility via the pure and synthetic lumens, or tubular constructions, inside the human physique.
